Business
Cerus Corporation Announces Workshop and Abstracts at the 2023 AABB Annual Meeting
Workshop and Presentations Highlight the Benefits of Real-world Utilization of INTERCEPT-treated Blood Products, including the INTERCEPT Blood System for
About this update from Cerus Corporation
[{"type":"text","content":"\nWorkshop and Presentations Highlight the Benefits of Real-world Utilization of INTERCEPT-treated Blood Products, including the INTERCEPT Blood System for Platelets and INTERCEPT Fibrinogen Complex\n\n\n CONCORD, Calif.--(BUSINESS WIRE)--\nCerus Corporation (Nasdaq:CERS) today announced a selection of abstracts and an industry workshop at the 2023 AABB Annual Meeting, taking place in Nashville, TN from October 14 through October 17. This year’s AABB Annual Meeting attracts individuals and institutions from around the globe involved in the fields of transfusion medicine and biotherapies.\n\n\nThe following is a select list of presentations and abstracts of interest for Cerus. All presentation times are listed in Central Daylight Time (CDT).\n\n\nOral Presentations\n\n\n\nSunday, October 15, 2023 – 10:00 a.m.– Pathogen Reduced Cryoprecipitate: Early Experiences and Inventory Management Outcomes (Chair: M.S. Virk, M.D., Stanford University; Speakers: A. Panigrahi, M.D., Ph.D., Stanford University; C. Webb, M.D., University of Texas Southwestern Medical Center)\n\n\n\nMonday, October 16, 2023 – 7:00 a.m. – Cerus Industry Workshop: Pathogen Reduced Cryoprecipitated Fibrinogen Complex (INTERCEPT Fibrinogen Complex or IFC) and Pathogen Reduced Cold Stored Platelets (PR-CSP): Expanding the Use of Pathogen Reduction for Improved Blood Safety and Availability (A. Alvarado, UCSF Health; P. Young, M.D., Ph.D., American Red Cross)\n\n\n\nMonday, October 16, 2023 – 5:30 p.m. – Implementation Of 100% Pathogen-Reduced And Extension Of Shelf Life Of Platelet Concentrates In France: A Retrospective Study On Impact On Platelet Issuing (P. Richard, Establissement Francais du Sang)\n\n\n\nPoster Presentations\n\n\nHeld between Sunday, October 15 and Monday, October 16, 2023\n\n\n\nSafety and Efficacy of Amotosalen-UVA Pathogen Reduced Platelet Components Transfused to Mature and Premature Neonates\n\n\n\nReduced Blood Bank Product Preparation Time and Waste with Implementation of Pathogen Reduced Cryoprecipitate\n\n\n\nImplementation of Pathogen Reduced Cryoprecipitated Fibrinogen Complex in a Pediatric Level II Trauma Center\n\n\n\nImproved Operational Efficiency with Pathogen Reduced Cryoprecipitated Fibrinogen Complex vs. CryoAHF\n\n\n\nDeveloping a Tool to Assess Red Blood Cell Clearance in Vivo Utilizing Pathogen-Reduced RBCs\n\n\n\nThe full p...